These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2182696)

  • 41. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchoconstriction due to isocapnic cold air inhalation minimally influences bronchial hyperresponsiveness to methacholine in asthmatic subjects.
    Malo JL; Cartier A; L'Archevêque J; Ghezzo H; Martin RR
    Bull Eur Physiopathol Respir; 1986; 22(5):473-7. PubMed ID: 3542088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma.
    Dempsey OJ; Fowler SJ; Wilson A; Kennedy G; Lipworth BJ
    Chest; 2002 Jul; 122(1):151-9. PubMed ID: 12114351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thyroid function in bronchial asthma].
    Biscaldi G; Fonte R; Rossi G; Guarnone F; Moscato G
    Recenti Prog Med; 1989; 80(7-8):430-3. PubMed ID: 2682856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of sensitivity and specifity of two bronchial provocation tests with methacholine and hypertonic saline in bronchial hyperreactivity evaluation in asthmatics].
    Piotrowska T; Siergiejko G; Siergiejko Z
    Pol Merkur Lekarski; 2007 Feb; 22(128):126-9. PubMed ID: 17598657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Theophylline vs. budesonide in the treatment of mild-to-moderate bronchial asthma.
    Matthys H; Müller S; Herceg R
    Respiration; 1994; 61(5):241-8. PubMed ID: 7800954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of the use of choline theophyllinate and a sustained-release theophylline in adults with chronic asthma.
    Chan KW; Lee HS; Ti TY; Tan TH; Feng PH
    Ann Acad Med Singap; 1985 Jul; 14(3):470-4. PubMed ID: 4073814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term xanthine therapy of asthma. Enprofylline and theophylline compared. International Enprofylline Study Group.
    Chapman KR; Ljungholm K; Kallen A
    Chest; 1994 Nov; 106(5):1407-13. PubMed ID: 7956392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma.
    Furukawa CT; Shapiro GG; Bierman CW; Kraemer MJ; Ward DJ; Pierson WE
    Pediatrics; 1984 Oct; 74(4):453-9. PubMed ID: 6435085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
    Ferdousi HA; Dreborg S
    Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects.
    Mapp C; Boschetto P; dal Vecchio L; Crescioli S; de Marzo N; Paleari D; Fabbri LM
    Am Rev Respir Dis; 1987 Dec; 136(6):1403-7. PubMed ID: 2825567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of posture on expiratory flows and airway responsiveness to methacholine in asthma.
    Tahan M; Boulet LP
    Chest; 1993 Jul; 104(1):143-8. PubMed ID: 8325059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
    Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction in the oral doses of theophylline in asthmatic children during concomitant treatment with ketotifen.
    Solé D; Mallozi MC; Toledo EC; Passos Soares FJ; Naspitz CK
    Allergol Immunopathol (Madr); 1992; 20(2):57-60. PubMed ID: 1442450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between recurrent croup and airway hyperreactivity.
    Litmanovitch M; Kivity S; Soferman R; Topilsky M
    Ann Allergy; 1990 Sep; 65(3):239-41. PubMed ID: 2206090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of alterations of dietary sodium on the severity of asthma in men.
    Carey OJ; Locke C; Cookson JB
    Thorax; 1993 Jul; 48(7):714-8. PubMed ID: 8153919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission.
    Boulet LP; Turcotte H; Brochu A
    Chest; 1994 Apr; 105(4):1024-31. PubMed ID: 8162720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latanoprost and respiratory function in asthmatic patients: randomized, double-masked, placebo-controlled crossover evaluation.
    Hedner J; Everts B; Möller CS
    Arch Ophthalmol; 1999 Oct; 117(10):1305-9. PubMed ID: 10532438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.